Relay Therapeutics, Inc. (NASDAQ: RLAY) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT RELAY THERAPEUTICS, INC.

Relay Therapeutics, Inc. (NASDAQ: RLAY)
Listen to this Section


$17.86
-0.1640 ( -0.91% ) 1.8M

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Market Data


Open $17.86
Previous Close $18.02
Volume 1.8M
Market Cap $3.93B
Day Range $17.85 - $18.94
52 Week Range $3.03 - $18.94
Shares Outstanding 217.94M
Change % -0.91%
Net Change ▼ -0.1640
Insider Ownership -0.04%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,958,579.00

Date Type Amount Purchased Purchaser
2024-07-31 Sale -1638.00 Adams Brian
2024-07-31 Sale -1702.00 Catinazzo Thomas
2024-07-31 Sale -1359.00 Rahmer Peter
2024-07-31 Sale -2698.00 Bergstrom Donald A
2024-07-29 Sale -50000.00 Patel Sanjiv
2024-07-01 Sale -2108.00 Patel Sanjiv
2024-07-01 Sale -295.00 Adams Brian
2024-07-01 Sale -245.00 Rahmer Peter
2024-07-01 Sale -648.00 Bergstrom Donald A
2024-07-01 Sale -295.00 Catinazzo Thomas

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 57 Nov 06, 2025
4 Insider transactions 1 Nov 06, 2025
4 Insider transactions 1 Nov 06, 2025
3 Insider transactions 2 Nov 06, 2025
3 Insider transactions 2 Nov 06, 2025
8-k 8K-related 12 Nov 06, 2025
4 Insider transactions 2 Nov 04, 2025
4 Insider transactions 2 Oct 30, 2025
4 Insider transactions 2 Oct 30, 2025
4 Insider transactions 2 Oct 30, 2025

Latest News